ESH 2023: hypertension, underestimated emergency
European Society of Hypertension 32nd scientic meeting
ESH 2023: hypertension, underestimated emergency
European Society of Hypertension 32nd scientic meeting
Hypertension is a silent killer, still largely underdiagnosed, affecting nearly 1.3 billion people worldwide. The ESH 2023 scientific event provided the opportunity to remind specialists and decision-makers of health systems of the qualitative and quantitative terms of this mega-pandemic, reviewing the diagnostic-therapeutic and behavioral elements already available to operators and patients , which if properly used would drastically reduce the extent of the phenomenon.
Hypertension is a silent killer, still largely underdiagnosed, affecting nearly 1.3 billion people worldwide. The ESH 2023 scientific event provided the opportunity to remind specialists and decision-makers of health systems of the qualitative and quantitative terms of this mega-pandemic, reviewing the diagnostic-therapeutic and behavioral elements already available to operators and patients , which if properly used would drastically reduce the extent of the phenomenon.
Hypertension, an underestimated threat. The new tools to fight it
it
Prof. Stefano Taddei
ESH Guidelines 2023: improving the control of hypertension as a risk factor
it
Prof. Gianfranco Parati
A study on patient preferences for renal denervation or drugs
en
Prof. Atul Pathak
New ESH guidelines: focus on comorbidities and new treatments
en
Prof. Konstantinos Tsioufis
Uncontrolled hypertension: a paradigmatic clinical case
en
Prof. Roland Schmieder
Two clinical cases on renal denervation treatment
en
Prof. Yaron Arbel
Antihypertensive drugs: novelties and re-evaluations in the ESH guidelines
en
Prof. Michel Burnier
Functional status, not the age, is the criterion for elderly treatment
en
Prof. Athanasios Benetos
Preventing stroke and dementhia. The new targets
en
Prof. Dagmara Hering
Blood pressure control after a stroke
en
Prof. Alastair Webb